feed,title,long_url,short_url
Benzinga,Truist Sees 350% Upside On This Cancer-Focused Biopharma Stock - Read Why,https://benzinga.com/general/biotech/22/03/26066252/truist-sees-350-upside-on-this-cancer-focused-biopharma-stock-read-why,https://bit.ly/3pRleTH
